Integrative oncology consultation clinic with herbal apothecary and acupuncture suite

CLINICAL APPLICATION & CRITERIA

Integrative Chinese & Western Medicine in China

Traditional Chinese Medicine (TCM) is a holistic healing system with over 2,000 years of clinical history, encompassing herbal formulas, acupuncture, moxibustion, therapeutic exercise (tai chi, qigong), and dietary therapy. In modern oncology, TCM is most commonly used as an evidence-based integrative complement to surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy — not as a replacement for them. Its primary recognized roles are reducing treatment-related toxicity, improving quality of life, alleviating symptoms such as fatigue, nausea, pain, and neuropathy, enhancing immune function, and potentially extending survival in advanced disease through a ‘survival with tumor’ approach supported by modern clinical research.

  • Toxicity Reduction During Chemoradiotherapy
  • Radiation Side-Effect Management
  • Immune Modulation
  • Personalized Pattern Differentiation
  • Rehabilitation & Survivorship
  • Whole-Person Care

CLINICAL CANCER INDICATIONS

Key Cancers Supported by Integrative Oncology in China

Authentic evidence-based botanical synergy, toxicity reduction, and whole-person survivorship pathways integrated into Western oncology lines:

Stomach & Colorectal Cancer

Spleen-strengthening herbal decoctions and Kanglaite injections reversing chemo-induced anorexia, severe nausea, and peripheral neuropathy.
Learn More

Lung Cancer

Nourishing-yin herbal formulas and acupuncture mitigating radiation-induced pneumonitis, dry cough, and systemic fatigue during targeted therapy.
Learn More

Breast Cancer

Targeted botanical formulations managing post-surgical lymphedema, aromatase inhibitor joint pain, hot flashes, and menopausal symptoms.
Learn More

WHY CHOOSE US

Why Choose China Cancer Help for Integrative Oncology

A specialized cross-border continuum providing international patients with authentic, evidence-based integrative oncology in China.

TCM is uniquely indigenous to China, where approximately 70% of cancer patients use TCM at some point during their treatment, and it is formally integrated into the national cancer control strategy through the Healthy China Action Plan (2023–2030). Top TCM oncology centers — Guang’anmen Hospital, Xiyuan Hospital, and Longhua Hospital under the China Academy of Chinese Medical Sciences — have accumulated decades of clinical experience and conduct multicenter randomized controlled trials on integrative cancer care.

Government policy explicitly supports TCM-Western medicine integration (zhong xi yi jie he), with dedicated TCM cancer wards, joint multidisciplinary clinics, and national TCM oncology guidelines. Chinese researchers have made globally significant discoveries rooted in TCM — most notably arsenic trioxide for acute promyelocytic leukemia, now a standard cure worldwide. Herbal formulas, acupuncture, and integrative rehabilitation programs are highly cost-effective, and leading centers offer international patient services with bilingual coordinators, making China the natural destination for patients seeking evidence-based, culturally authentic integrative oncology care.

CASE EVALUATION PATHWAY

A Structured Pathway from Records to Care

A transparent, four-stage continuum connecting preliminary clinical evaluation to official hospital acceptance, specialized inpatient care, and ongoing continuity.

01. Submit Records Online

Upload existing pathology reports, biomarker NGS profiles, and imaging scans through our secure clinical intake portal.

02. Pre-Screen & Doctor Match

Clinical eligibility and contraindication screening, matching your specific case with China's foremost oncology chiefs.

03. Doctor Consultation

One-on-one remote video consultation or written multidisciplinary assessment to confirm treatment protocol before travel.

04. Travel to China & Care

Expedited medical visa support, priority hospital admission, dedicated bilingual bedside escorts, and continuum follow-up.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international Integrative Chinese & Western Medicine patients considering care in China.

In China’s Grade 3A hospitals, TCM oncologists work side-by-side with surgical and medical oncologists. TCM does not replace standard curative therapies but is administered concurrently to reduce toxicity, protect bone marrow, enhance response, and speed recovery.
Yes. Hospital-grade preparations such as Kanglaite (coix seed oil) and Shenqi Fuzheng injections are rigorously standardized, NMPA-approved pharmaceutical formulations with extensive Phase III clinical trial data confirming safety and non-interference with Western drug metabolism.
Yes. Chinese hospital pharmacies dispense standardized concentrated herbal granules or vacuum-sealed decoctions with official bilingual medical prescriptions and customs documentation for continued home use.
Clinical trials demonstrate that specialized hospital acupuncture significantly reduces chemotherapy-induced nausea and vomiting (CINV), alleviates cancer-related fatigue, eases postoperative pain, and improves sleep quality without pharmacological interactions.

INTEGRATIVE CHINESE & WESTERN MEDICINE PRE-ASSESSMENT

Request a Confidential Case Review for Integrative Chinese & Western Medicine

Submit your contact details, confirmed diagnosis, and main question below. You do not need to upload any medical files at this stage. Our clinical coordinator will contact you directly within 24–48 hours to discuss potential integrative oncology pathways in China and assist you in gathering the specific medical records needed for expert hospital review.

    Integrative Chinese & Western Medicine